A novel computational framework integrating viral evolution modeling and immunology has identified broadly neutralizing antibodies against current and anticipated SARS-CoV-2 variants. This proactive approach advances antibody therapy development, offering a promising strategy to counteract viral mutation and enhance COVID-19 therapeutic resilience.